Merck secures FDA approval for Keytruda and Lenvima combination to treat endometrial carcinoma
The FDA approval marks the first anti-PD-1 therapy tom be approved in combination with a kinase inhibitor for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
18 Sep 19
The FDA approval marks the first anti-PD-1 therapy tom be approved in combination with a kinase inhibitor for…
17 Sep 19
The proposed transaction is expected to strengthen Lundbeck’s operations, accelerate its late-stage pipeline, and provides access to new…
16 Sep 19
The FDA has granted Fast Track designation to abexinostat, in combination with pazopanib, as a first- or second-line…
13 Sep 19
The results from the SAkuraStar clinical study demonstrated use of satralizumab as monotherapy reduced 55% risk of relapses…
11 Sep 19
OCREVUS is a humanised monoclonal antibody designed to target CD20-positive B cells, a specific type of immune cell…
10 Sep 19
Pfizer enrolled subjects for the Phase 3 Study of its 20-Valent Pneumococcal Conjugate Vaccine Candidate for the prevention…
06 Sep 19
SunGen has opened its injectable division through the acquisition of a New Jersey-based pharmaceutical company
06 Sep 19
Phase III trial TAGS is designed to evaluate LONSURF in combination with best supportive care (BSC), with placebo…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Sep 19
Theragnostics’ technology platform enables the development of molecular radiotherapy based on a PARPi for imaging and treating cancer
04 Sep 19
US-based biopharmaceutical company Vertex has signed a definitive agreement to acquire Semma Therapeutics, a USK-based biotechnology company, for…